1. Home
  2. ALLR vs EZGO Comparison

ALLR vs EZGO Comparison

Compare ALLR & EZGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$1.30

Market Cap

25.6M

Sector

Health Care

ML Signal

HOLD

Logo EZGO Technologies Ltd.

EZGO

EZGO Technologies Ltd.

HOLD

Current Price

$1.25

Market Cap

28.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLR
EZGO
Founded
2004
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Motor Vehicles
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
25.6M
28.4M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
ALLR
EZGO
Price
$1.30
$1.25
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$9.75
N/A
AVG Volume (30 Days)
145.6K
1.4M
Earning Date
05-15-2026
07-01-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$320,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$0.01
52 Week High
$2.35
$3.30

Technical Indicators

Market Signals
Indicator
ALLR
EZGO
Relative Strength Index (RSI) 41.98 47.39
Support Level $1.28 $1.19
Resistance Level $1.43 $1.32
Average True Range (ATR) 0.12 0.19
MACD -0.01 -0.03
Stochastic Oscillator 19.41 17.65

Price Performance

Historical Comparison
ALLR
EZGO

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

About EZGO EZGO Technologies Ltd.

EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.

Share on Social Networks: